Feasibility of a novel implantable device to provide heart failure therapy and left atrial pressure monitoring in a chronic animal study

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Shuchen Ge

Shanghai (China)

5 More presentations in this session

Presentation thumbnail

Effect of qiliqiangxin according to N-terminal pro-B-type natriuretic peptide in patients with heart failure and reduced ejection fraction: insights from QUEST

Doctor L. Shen (Glasgow, CN)

Abstract Slides Video

Presentation thumbnail

Beneficial effects of treatment with a soluble guanylate cyclase stimulator on cardiac function and mitochondrial activity in an animal model of early-stage HFpEF

Mr X. Vazquez-Abuin (Santiago De Compostela, ES)

Abstract Slides Video

Presentation thumbnail

Amyloid-beta metabolism, cardiac remodeling and myocardial recovery in advanced heart failure

Doctor G. Zervas (Athens, GR)

Abstract Slides Video

Presentation thumbnail

Xanthine oxidase inhibitors in cardiovascular disease: impact on mortality and ATP dynamics

Associate Professor M. Kuwabara (Shimotsuke, JP)

Abstract Slides Video

Presentation thumbnail

Myeloid-specific Nrf2 deletion increases fibrosis and contributes to the development of heart failure after murine myocardial infarction

Miss T. Ali (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Basic concepts in heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Relationship between pulmonary artery wedge pressure and left atrial pressure: pathophysiologic implications

Congress Session

Late breaking clinical trials: devices

Congress Session

Interatrial shunt devices: a new tool for heart failure treatment?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources